| 5.85 |  +0.16 / +2.81% |
Data as of 4:00pm ET | Day’s Change |
| 5.85 |  0.00 / 0.00% |
Volume: 368.00 |
| Previous close | 5.69 |
| Today’s open | 5.61 |
| Day’s range | 5.50 - 5.98 |
| Volume | 7,729 |
| Average volume (3 months) | 57,075 |
| Market cap | $137.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -12,029.73% |
| Earnings growth (this year) | +83.66% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -69.89% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ENZNEnzon Pharmaceutical... | 0.00 | 0.00% |
| PTXPernix Therapeutics ... | +0.08 | +2.22% |
| ALIMAlimera Sciences Inc | +0.01 | +0.23% |
| AVEOAveo Pharmaceuticals... | +0.01 | +0.37% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $6.1M |
| Annual profit (last year) | -$23.5M |
| Net profit margin | -385.52% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director David W. Pritchard, MBA |
Chief Financial Officer Jeffrey H. Cooper, MBA, CPA |
Corporate headquarters South San Francisco, California |
.
